Shares of Evotec SE (ETR:EVT – Get Free Report) hit a new 52-week low during trading on Monday . The stock traded as low as €8.01 ($8.80) and last traded at €8.02 ($8.81), with a volume of 1294018 shares changing hands. The stock had previously closed at €8.01 ($8.80).
Evotec Price Performance
The company has a quick ratio of 2.97, a current ratio of 1.94 and a debt-to-equity ratio of 55.91. The business has a 50-day moving average price of €8.79 and a two-hundred day moving average price of €11.40. The company has a market capitalization of $1.42 billion, a price-to-earnings ratio of -16.02, a price-to-earnings-growth ratio of 0.98 and a beta of 1.17.
Evotec Company Profile
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Recommended Stories
- Five stocks we like better than Evotec
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- From Tokyo to Wall Street: Japan’s Market Impact on U.S. Stocks
- Bank Stocks – Best Bank Stocks to Invest In
- Arm Holdings: Does the 42% Drop Signal an AI Buying Opportunity?
- Best Stocks Under $5.00
- Texas Roadhouse Stampedes On EPS Beat as Comp Sales Surge 9.3%
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
